• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚2型糖尿病经济状况与严重程度之间的相关性:对2018 - 2022年国家健康保险计划索赔数据的分析

Correlation between economic status and severity of type 2 diabetes mellitus in Indonesia: analysis of claim data from the national health insurance scheme, 2018-2022.

作者信息

Ahsan Abdillah, Baros Wan Aisyiah, Siregar Dedy Revelino, Pertiwi Yuyu Buono Ayuning, Utami Maulida Gadis, Aminde Leopold, Manurung Khaterina Kristina, Febriyanti Maya

机构信息

Department of Economics, University of Indonesia Faculty of Economics and Business, Depok, Indonesia

Badan Penyelenggara Jaminan Sosial Kesehatan, Jakarta, Indonesia.

出版信息

BMJ Open. 2025 May 2;15(5):e091115. doi: 10.1136/bmjopen-2024-091115.

DOI:10.1136/bmjopen-2024-091115
PMID:40316359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049868/
Abstract

OBJECTIVES

This study investigated the correlation between the type of health insurance membership as a proxy for the economic status of patients and the severity of their type two diabetes mellitus (T2DM) in Indonesia.

DESIGN

The study conducted a secondary analysis of National Health Insurance (Jaminan Kesehatan Nasional) claim data provided by the Indonesian Social Security Agency, (BPJS). We used ordered logistic regression with four severity levels for T2DM (0=outpatient, I=mild, II=moderate, III=severe) as dependent variables. The main independent variables (insurance membership categories) included subsidised insurance members (PBI), a combination of formally employed and nonsalaried informal workers (PBPU & PPU) and nonworkers (BP).

SETTING

Secondary healthcare facilities in Indonesia.

PARTICIPANTS

The dataset included 2 989 618 claims for hospital visits of people with T2DM from 2018 to 2022.

PRIMARY OUTCOME MEASURES

Severity level of T2DM patients.

RESULT

A higher percentage of T2DM patients who visited healthcare facilities with subsidised insurance (PBI), which represents a low-income group, have severe disease (6.9%) than patients in the PBPU & PPU (4.9%) and BP categories (5.5%). Moreover, regression analysis revealed that having PBI membership status was associated with a greater OR of having severe T2DM than nonsubsidised members. Among T2DM patients in the nonsubsidised insurance category, workers (PBPU & PPU) had an OR of 0.74 (95% CI: 0.735 to 0.745; p<0.0001) for having severe disease during hospital visits. Moreover, non-workers (BP) had a lower OR of 0.718 (95% CI: 0.711 to 0.725; p<0.0001) for severe disease than the PBI category.

CONCLUSION

These findings illustrate the lack of optimal access to health services for diabetes patients in low-income insurance membership categories and the challenges of better treatment in health facilities for low-income patients.

摘要

目的

本研究调查了作为患者经济状况指标的医疗保险类型与印度尼西亚2型糖尿病(T2DM)患者病情严重程度之间的相关性。

设计

该研究对印度尼西亚社会保障局(BPJS)提供的国民健康保险(Jaminan Kesehatan Nasional)索赔数据进行了二次分析。我们使用有序逻辑回归,将T2DM的四个严重程度级别(0 = 门诊,I = 轻度,II = 中度,III = 重度)作为因变量。主要自变量(保险会员类别)包括补贴保险会员(PBI)、正式雇员和非受薪非正式工人的组合(PBPU & PPU)以及非工人(BP)。

地点

印度尼西亚的二级医疗设施。

参与者

该数据集包括2018年至2022年期间2989618例T2DM患者的医院就诊索赔。

主要观察指标

T2DM患者的严重程度级别。

结果

在代表低收入群体的补贴保险(PBI)类别中,前往医疗机构就诊的T2DM患者中患有严重疾病的比例(6.9%)高于PBPU & PPU类别(4.9%)和BP类别(5.5%)的患者。此外,回归分析显示,拥有PBI会员身份与患有严重T2DM的比值比高于非补贴会员。在非补贴保险类别的T2DM患者中,工人(PBPU & PPU)在医院就诊期间患有严重疾病的比值比为0.74(95%置信区间:0.735至0.745;p<0.0001)。此外,非工人(BP)患有严重疾病的比值比(0.718,95%置信区间:0.711至0.725;p<0.0001)低于PBI类别。

结论

这些发现表明低收入保险会员类别中的糖尿病患者缺乏获得最佳医疗服务的机会,以及低收入患者在医疗机构中获得更好治疗面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/b66cd61c508c/bmjopen-15-5-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/6fbf2492712a/bmjopen-15-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/1b48799aa381/bmjopen-15-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/b66cd61c508c/bmjopen-15-5-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/6fbf2492712a/bmjopen-15-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/1b48799aa381/bmjopen-15-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f3/12049868/b66cd61c508c/bmjopen-15-5-g003.jpg

相似文献

1
Correlation between economic status and severity of type 2 diabetes mellitus in Indonesia: analysis of claim data from the national health insurance scheme, 2018-2022.印度尼西亚2型糖尿病经济状况与严重程度之间的相关性:对2018 - 2022年国家健康保险计划索赔数据的分析
BMJ Open. 2025 May 2;15(5):e091115. doi: 10.1136/bmjopen-2024-091115.
2
Availability and Accessibility of Primary Care for the Remote, Rural, and Poor Population of Indonesia.印度尼西亚偏远、农村和贫困人口的初级保健的可及性和可及性。
Front Public Health. 2021 Sep 21;9:721886. doi: 10.3389/fpubh.2021.721886. eCollection 2021.
3
Why Do Informal Sector Workers Not Pay the Premium Regularly? Evidence from the National Health Insurance System in Indonesia.为什么非正式部门工人没有定期缴纳保费?来自印度尼西亚国家健康保险制度的证据。
Appl Health Econ Health Policy. 2020 Feb;18(1):81-96. doi: 10.1007/s40258-019-00518-y.
4
Behind the Hospital Ward: In-Hospital Mortality of Type 2 Diabetes Mellitus Patients in Indonesia (Analysis of National Health Insurance Claim Sample Data).医院病房背后:印度尼西亚 2 型糖尿病患者的院内死亡率(国家健康保险索赔样本数据分析)。
Int J Environ Res Public Health. 2024 May 1;21(5):581. doi: 10.3390/ijerph21050581.
5
Determinants of healthcare utilization under the Indonesian national health insurance system - a cross-sectional study.印度尼西亚国家医疗保险制度下医疗服务利用的决定因素——一项横断面研究。
BMC Health Serv Res. 2025 Jan 9;25(1):48. doi: 10.1186/s12913-024-11951-8.
6
What are the factors affecting primary care choice when the access under health insurance scheme is limited?: a cross-sectional study in Bandung, Indonesia.在医疗保险计划下的可及性受到限制时,影响初级保健选择的因素有哪些?:印度尼西亚万隆的一项横断面研究。
BMC Prim Care. 2024 Feb 21;25(1):64. doi: 10.1186/s12875-024-02296-6.
7
Cost burden of chemotherapy for Indonesian healthcare insurance and social security/Jaminan Kesehatan Nasional (JKN) patients with non-Hodgkin lymphoma.印度尼西亚医疗保险和社会保障(JKN)患者非霍奇金淋巴瘤化疗的费用负担。
J Oncol Pharm Pract. 2024 Sep;30(6):1096-1100. doi: 10.1177/10781552241261250. Epub 2024 Jun 11.
8
Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia.印度尼西亚 2 型糖尿病及其相关并发症的直接医疗费用。
Value Health Reg Issues. 2022 Mar;28:82-89. doi: 10.1016/j.vhri.2021.04.006. Epub 2021 Nov 25.
9
Navigating the aftermath: Risk factors of recurrence following coronary bypass surgery in Indonesia.应对后果:印度尼西亚冠状动脉搭桥手术后复发的风险因素
Narra J. 2024 Dec;4(3):e969. doi: 10.52225/narra.v4i3.969. Epub 2024 Oct 11.
10
Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea.韩国国家健康保险索赔数据中 2 型糖尿病患者胰岛素的使用模式。
PLoS One. 2019 Mar 6;14(3):e0210159. doi: 10.1371/journal.pone.0210159. eCollection 2019.

本文引用的文献

1
Income Disparity and Healthcare Utilization: Lessons from Indonesia's National Health Insurance Claim Data.收入差距与医疗保健利用:来自印度尼西亚国家健康保险索赔数据的经验教训。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3397-3402. doi: 10.31557/APJCP.2023.24.10.3397.
2
Telenursing needs and influencing factors in patients with type 2 diabetes mellitus: A cross-sectional study.2 型糖尿病患者远程护理需求及影响因素的横断面研究。
J Clin Nurs. 2023 Oct;32(19-20):7298-7309. doi: 10.1111/jocn.16805. Epub 2023 Jun 19.
3
A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.
一项随机、阳性对照、平行、开放标签、多中心、四期研究,旨在比较普瑞巴林缓释片和普瑞巴林速释胶囊在 II 型糖尿病周围神经痛患者中的疗效和安全性。
Medicine (Baltimore). 2023 Apr 25;102(17):e33701. doi: 10.1097/MD.0000000000033701.
4
A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM).一种通过数字健康来管理 2 型糖尿病的基于数据驱动的方法:Klivo 干预计划方案(KIPDM)。
PLoS One. 2023 Feb 24;18(2):e0281844. doi: 10.1371/journal.pone.0281844. eCollection 2023.
5
Disease Management Program in patients with type 2 diabetes mellitus, long-term results of the early and established program cohort: A population-based retrospective cohort study.2 型糖尿病患者疾病管理计划:早期和已建立计划队列的长期结果:一项基于人群的回顾性队列研究。
PLoS One. 2022 Dec 13;17(12):e0279090. doi: 10.1371/journal.pone.0279090. eCollection 2022.
6
Changes in Glycemic Control Following Use of a Spanish-Language, Culturally Adapted Diabetes Program: Retrospective Study.使用西班牙语、文化适应性糖尿病项目后血糖控制的变化:回顾性研究
JMIR Form Res. 2022 Dec 7;6(12):e40278. doi: 10.2196/40278.
7
Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.血清 miR-29a 在糖尿病肾病发生和进展中的意义:一项横断面研究。
J Clin Lab Anal. 2022 Feb;36(2):e24210. doi: 10.1002/jcla.24210. Epub 2021 Dec 28.
8
A pragmatic randomised controlled trial referring to a Personalised Self-management SUPport Programme (P-SUP) for persons enrolled in a disease management programme for type 2 diabetes mellitus and/or for coronary heart disease.一项针对参加 2 型糖尿病和/或冠心病疾病管理计划的个体的个性化自我管理支持计划(P-SUP)的实用随机对照试验。
Trials. 2021 Sep 27;22(1):659. doi: 10.1186/s13063-021-05636-4.
9
Vibrotactile sense might improve over time in paediatric subjects with type 1 diabetes-A mid-term follow-up using multifrequency vibrometry.多频震动觉测量评估 1 型糖尿病患儿触觉震动觉:中期随访研究
Acta Paediatr. 2022 Feb;111(2):411-417. doi: 10.1111/apa.16124. Epub 2021 Oct 1.
10
The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting.印度尼西亚慢性病管理计划(PROLANIS)对初级保健环境中 2 型糖尿病患者代谢控制和肾功能的影响。
J Prim Care Community Health. 2021 Jan-Dec;12:2150132720984409. doi: 10.1177/2150132720984409.